![]() |
![]() | ![]() |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
Cephalon is coming up on an extended FDA ruling. The stock is @ $12 and there has been growing volume and has come up off a low of 9 3/8 it has been up in the $40's in the recent past. I have spoken with the company and done my DD. This is a stock that fell out of favor and was forgotten. They have contracts with Chiron and a strong pipeline of Drugs and other NDA's. Bye,Bye | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |